Main > HEPATOLOGY > Hepatitis B Virus > Infection. Treatment > Thymosin Alpha-1 (Peptide) > Co.: USA. S (Development/Patents) > Status> > Combi. LamivudineTherapy (Taiwan)>
Currently, Co. is enrolling up to 120 patients in a clinical trial in Taiwan using drug in combination with lamivudine for the treatment of HBV. Previously reported data from small pilot trials suggest that drug combination therapy could increase the response rate for patients taking lamivudine or interferon alone.
Combi. LamivudineTherapy (Taiwan)>'s products
This section has no products